It appears that what Array is trying to do is focus on oncology while the new subsidiary focuses on rare diseases. Source: BioSpace

A look at a small-cap biotech company that investors should consider. Source: BioSpace

Mallinckrodt picks up Sucampo’s Amitiza as well as two other pipeline compounds. Source: BioSpace

The round was led by Berkshire Partners and TPG Growth, with participation from its co-founders and management team, as well as original investors Oak Investment Partners and J.H. Whitney. Source:…

Dr. Lias succeeds Steven W. King, who resigned as president and chief executive officer of Peregrine to pursue other professional interests. Source: BioSpace

Shire filed its first submission to the FDA for its new plasma manufacturing site in Covington, Georgia. Source: BioSpace

North Carolina sued Insys on Thursday, accusing the pharmaceutical company of illegally pushing a powerful fentanyl-based cancer pain medicine called Subsys to boost profits amid the U.S. opioid epidemic. Source:…

Pfizer may be the surprise strong-growth stock for next year. Source: BioSpace

Biotechnology major BioCon is likely to take its group entity Biocon Biologics public and is expected to raise about $500M. Source: BioSpace

With a priority review voucher in hand, Teva is expecting the FDA to rule on its new migraine treatment fremanezumab by June. Source: BioSpace